Latest News & Features
Big Pharma
Feud involved a blockbuster cancer drug belonging to a family of PARP inhibitors | GSK unit failed to persuade the court of the merits of its ‘certain uses’ argument. 6 April 2023
Biotechnology
Arbutus and Genevant claims Pfizer/BioNTech vaccine uses patented technology | Claim follows last year’s lawsuit against Moderna. 6 April 2023
Generics
Lawsuit is second to be filed in Delaware over Abbvie’s Orilissa treatment | Abbive says Teva’s ANDA infringes patent granted in January. 4 April 2023
Big Pharma
The three companies will make low-cost versions of HIV PrEP drug | Generics will be available to consumers in 90 low- and middle-income countries. 30 March 2023
Americas
H&H Wholesale Services found to have committed ‘fraud on the court’ | Final amount includes attorneys’ fees and costs. 30 March 2023
Biotechnology
Recruit from DLA Piper brings two decades of patent and technical experience in life sciences, biotechnology, and healthcare industries. 28 March 2023
Europe
Board provides guidance on evidence submitted after patent filing date | Eagerly awaited decision confirms what’s needed to prove a certain effect. 28 March 2023
Big Pharma
NIH rejects petition to use “march-in” rights to allow cheaper competition | Xtandi is “widely available” to public, federal agency says. 23 March 2023
Big Pharma
Hikma label and public statements encouraged infringement, Amarin says | Delaware District Court had dismissed claims label was ‘not skinny enough’. 23 March 2023
Big Pharma
Cipla claims Cabometyx patents are invalid | Exelixis wants generic blocked until at least 2030. 21 March 2023